WuXi AppTec and its sister company WuXi Biologics have reiterated they are growing their North American footprint, despite ...
WuXi AppTec reportedly transferred a US client’s intellectual property to Chinese authorities, American intelligence ...
After a better-than-expected launch, Nestlé Health Science is planning its next commercialization moves for Vowst, an oral ...
The FDA expanded the label for Gilead’s hepatitis B drug Vemlidy on Thursday to patients as young as 6 years old. Vemlidy, or ...
Aldeyra Therapeutics is planning to resubmit an NDA for its dry eye disease drug in the second half of this year, though ...
Senate HELP Committee Chair Bernie Sanders (I-VT) is calling on Novo Nordisk to dramatically lower the list prices of Ozempic ...
Pelago, which provides digital substance use treatment for substances like opioids and tobacco, said it is expanding to cover ...
Intellihealth signed on its largest client last year when it began providing weight-loss care and prescribing GLP-1s to ...
There’s no word yet on when Metagenomi will enter the clinic. In its first quarterly update as a public company, the ...
Plus, news about Praxis, Pieris, Ironwood, Stoke and Milestone Pharmaceuticals: Bayer to cut 90 jobs after leadership cuts: The German conglomerate’s layoff plans were unveiled in a New Jersey Worker ...
Ovid Therapeutics is ramping up its patent fight with Marinus Pharmaceuticals. The rival biotechs have been battling for more ...
Xilio Ther­a­peu­tics had a bevy of an­nounce­ments on Thurs­day — it en­tered a li­cens­ing deal for its Phase 1 IL-12 ...